▶ 調査レポート

自己免疫薬の中国市場2017

• 英文タイトル:China Autoimmune Drugs Market Research Report 2017

QYResearchが調査・発行した産業分析レポートです。自己免疫薬の中国市場2017 / China Autoimmune Drugs Market Research Report 2017 / A042117553資料のイメージです。• レポートコード:A042117553
• 出版社/出版日:QYResearch / 2017年3月17日
• レポート形態:英文、PDF、121ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥339,200 (USD3,200)▷ お問い合わせ
  Enterprise¥678,400 (USD6,400)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、自己免疫薬の中国市場について調査・分析し、自己免疫薬の中国市場概観、自己免疫薬の種類別市場分析、用途別市場分析、自己免疫薬の中国市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、中国市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・自己免疫薬の中国市場概観
・自己免疫薬の種類別市場規模
・自己免疫薬の用途別市場規模
・自己免疫薬の中国市場規模
・自己免疫薬の中国市場予測
・自己免疫薬の製造メーカー分析
・自己免疫薬のメーカー別生産量
・自己免疫薬のメーカー別市場シェア
・自己免疫薬の価格動向・価格分析
・自己免疫薬の販売(売上高)動向
・自己免疫薬の貿易(輸出・輸入)動向
・自己免疫薬の産業チェーン分析
・自己免疫薬のマーケティング戦略分析
・自己免疫薬の販売業者(代理店)リスト
・自己免疫薬の市場環境分析
...

Notes:Sales, means the sales volume of Autoimmune Drugs
Revenue, means the sales value of Autoimmune Drugs

This report studies Autoimmune Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
AbbVie
Johnson & Johnson
Biogen
Amgen
Pfizer
F. Hoffmann-La Roche
AstraZeneca
GSK
Merck
Boehringer Ingelheim
Eli Lilly
Novartis
Sanofi
Takeda Pharmaceuticals
Vertex Pharmaceuticals
Eisai
Lexicon Pharmaceuticals
KaloBios Pharmaceuticals
Can-Fite BioPharma
Antares Pharma
Acorda Therapeutics

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
Psoriasis
Inflammatory Bowel Disease (IBD)
Ankylosing Spondylitis (AS)
Systemic Lupus Erythematosus (SLE)
Split by Application, this report focuses on consumption, market share and growth rate of Autoimmune Drugs in each application, can be divided into
Hospital
Clinic

レポート目次

Table of Contents

China Autoimmune Drugs Market Research Report 2017
1 Autoimmune Drugs Market Overview
1.1 Product Overview and Scope of Autoimmune Drugs
1.2 Autoimmune Drugs Segment by Type
1.2.1 China Production Market Share of Autoimmune Drugs Type in 2015
1.2.2 Rheumatoid Arthritis (RA)
1.2.3 Multiple Sclerosis (MS)
1.2.4 Psoriasis
1.2.5 Inflammatory Bowel Disease (IBD)
1.2.6 Ankylosing Spondylitis (AS)
1.2.7 Systemic Lupus Erythematosus (SLE)
1.3 Applications of Autoimmune Drugs
1.3.1 Autoimmune Drugs Consumption Market Share by Application in 2015
1.3.2 Hospital
1.3.3 Clinic
1.4 China Market Size (Value) of Autoimmune Drugs (2012-2022)
1.5 China Autoimmune Drugs Status and Outlook
1.6 Government Policies

2 China Autoimmune Drugs Market Competition by Manufacturers
2.1 China Autoimmune Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Autoimmune Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Autoimmune Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Autoimmune Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Autoimmune Drugs Market Competitive Situation and Trends
2.5.1 Autoimmune Drugs Market Concentration Rate
2.5.2 Autoimmune Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Autoimmune Drugs Manufacturers Profiles/Analysis
3.1 AbbVie
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Autoimmune Drugs Product Type, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 AbbVie Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Johnson & Johnson
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Autoimmune Drugs Product Type, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Johnson & Johnson Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Biogen
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Autoimmune Drugs Product Type, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Biogen Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Amgen
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Autoimmune Drugs Product Type, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 Amgen Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Pfizer
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Autoimmune Drugs Product Type, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Pfizer Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 F. Hoffmann-La Roche
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Autoimmune Drugs Product Type, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 F. Hoffmann-La Roche Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 AstraZeneca
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Autoimmune Drugs Product Type, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 AstraZeneca Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 GSK
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Autoimmune Drugs Product Type, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 GSK Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Merck
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Autoimmune Drugs Product Type, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Merck Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Boehringer Ingelheim
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Autoimmune Drugs Product Type, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 Boehringer Ingelheim Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Eli Lilly
3.12 Novartis
3.13 Sanofi
3.14 Takeda Pharmaceuticals
3.15 Vertex Pharmaceuticals
3.16 Eisai
3.17 Lexicon Pharmaceuticals
3.18 KaloBios Pharmaceuticals
3.19 Can-Fite BioPharma
3.20 Antares Pharma
3.21 Acorda Therapeutics

4 China Autoimmune Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Autoimmune Drugs Capacity, Production and Growth (2012-2017)
4.2 China Autoimmune Drugs Revenue and Growth (2012-2017)
4.3 China Autoimmune Drugs Production, Consumption, Export and Import (2012-2017)

5 China Autoimmune Drugs Production, Revenue (Value), Price Trend by Type
5.1 China Autoimmune Drugs Production and Market Share by Type (2012-2017)
5.2 China Autoimmune Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Autoimmune Drugs Price by Type (2012-2017)
5.4 China Autoimmune Drugs Production Growth by Type (2012-2017)

6 China Autoimmune Drugs Market Analysis by Application
6.1 China Autoimmune Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Autoimmune Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaAutoimmune Drugs Market Analysis by Regions (Provinces)
7.1 China Autoimmune Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Autoimmune Drugs Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Autoimmune Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Autoimmune Drugs Sales Price by Regions (Provinces)(2012-2017)
7.2 China Autoimmune Drugs Consumption by Regions (Provinces)(2012-2017)
7.3 China Autoimmune Drugs Production, Consumption, Export and Import (2012-2017)

8 Autoimmune Drugs Manufacturing Cost Analysis
8.1 Autoimmune Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Autoimmune Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Autoimmune Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Autoimmune Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Autoimmune Drugs Market Forecast (2017-2022)
12.1 China Autoimmune Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Autoimmune Drugs Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Autoimmune Drugs Production Forecast by Type (2017-2022)
12.4 China Autoimmune Drugs Consumption Forecast by Application (2017-2022)
12.5 China Autoimmune Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Autoimmune Drugs Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Autoimmune Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Autoimmune Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Autoimmune Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Autoimmune Drugs
Figure China Production Market Share of Autoimmune Drugs by Type in 2015
Figure Product Picture of Rheumatoid Arthritis (RA)
Table Major Manufacturers of Rheumatoid Arthritis (RA)
Figure Product Picture of Multiple Sclerosis (MS)
Table Major Manufacturers of Multiple Sclerosis (MS)
Figure Product Picture of Psoriasis
Table Major Manufacturers of Psoriasis
Figure Product Picture of Inflammatory Bowel Disease (IBD)
Table Major Manufacturers of Inflammatory Bowel Disease (IBD)
Figure Product Picture of Ankylosing Spondylitis (AS)
Table Major Manufacturers of Ankylosing Spondylitis (AS)
Figure Product Picture of Systemic Lupus Erythematosus (SLE)
Table Major Manufacturers of Systemic Lupus Erythematosus (SLE)
Table Autoimmune Drugs Consumption Market Share by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure China Autoimmune Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table China Autoimmune Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Autoimmune Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Autoimmune Drugs Capacity of Key Manufacturers in 2015
Figure China Autoimmune Drugs Capacity of Key Manufacturers in 2016
Table China Autoimmune Drugs Production of Key Manufacturers (2015 and 2016)
Table China Autoimmune Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Autoimmune Drugs Production Share by Manufacturers
Figure 2016 Autoimmune Drugs Production Share by Manufacturers
Table China Autoimmune Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Autoimmune Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Autoimmune Drugs Revenue Share by Manufacturers
Table 2016 China Autoimmune Drugs Revenue Share by Manufacturers
Table China Market Autoimmune Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Autoimmune Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Autoimmune Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Autoimmune Drugs Product Type
Figure Autoimmune Drugs Market Share of Top 3 Manufacturers
Figure Autoimmune Drugs Market Share of Top 5 Manufacturers
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Autoimmune Drugs Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Autoimmune Drugs Market Share (2012-2017)
Table Biogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Biogen Autoimmune Drugs Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Autoimmune Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Autoimmune Drugs Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Autoimmune Drugs Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Autoimmune Drugs Market Share (2012-2017)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Autoimmune Drugs Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Autoimmune Drugs Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Autoimmune Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Autoimmune Drugs Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vertex Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lexicon Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table KaloBios Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Can-Fite BioPharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Antares Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acorda Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Autoimmune Drugs Capacity, Production and Growth (2012-2017)
Figure China Autoimmune Drugs Revenue (Million USD) and Growth (2012-2017)
Table China Autoimmune Drugs Production, Consumption, Export and Import (2012-2017)
Table China Autoimmune Drugs Production by Type (2012-2017)
Table China Autoimmune Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Autoimmune Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Autoimmune Drugs by Type
Table China Autoimmune Drugs Revenue by Type (2012-2017)
Table China Autoimmune Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Autoimmune Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Autoimmune Drugs by Type
Table China Autoimmune Drugs Price by Type (2012-2017)
Figure China Autoimmune Drugs Production Growth by Type (2012-2017)
Table China Autoimmune Drugs Consumption by Application (2012-2017)
Table China Autoimmune Drugs Consumption Market Share by Application (2012-2017)
Figure China Autoimmune Drugs Consumption Market Share by Application in 2015
Table China Autoimmune Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Autoimmune Drugs Consumption Growth Rate by Application (2012-2017)
Table China Autoimmune Drugs Production by Regions (Provinces)(2012-2017)
Table China Autoimmune Drugs Production Market Share by Regions (Provinces)(2012-2017)
Table China Autoimmune Drugs Production Value by Regions (Provinces)(2012-2017)
Table China Autoimmune Drugs Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Autoimmune Drugs Sales Price by Regions (Provinces)(2012-2017)
Table China Autoimmune Drugs Consumption by Regions (Provinces)(2012-2017)
Table China Autoimmune Drugs Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Autoimmune Drugs Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Autoimmune Drugs
Figure Manufacturing Process Analysis of Autoimmune Drugs
Figure Autoimmune Drugs Industrial Chain Analysis
Table Raw Materials Sources of Autoimmune Drugs Major Manufacturers in 2015
Table Major Buyers of Autoimmune Drugs
Table Distributors/Traders List
Figure China Autoimmune Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Autoimmune Drugs Revenue and Growth Rate Forecast (2017-2022)
Table China Autoimmune Drugs Production, Import, Export and Consumption Forecast (2017-2022)
Table China Autoimmune Drugs Production Forecast by Type (2017-2022)
Table China Autoimmune Drugs Consumption Forecast by Application (2017-2022)
Table China Autoimmune Drugs Production Forecast by Regions (Provinces)(2017-2022)
Table China Autoimmune Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Autoimmune Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)